https://www.selleckchem.com/pr....oducts/NVP-AUY922.ht
Biomarkers obtained with wide-field OCTA, such as indices quantitatively reflecting ischemia and neovascularization are paid special attention in the review. The problems and solutions associated with the use of OCTA-biomarkers in DR are also considered. In general OCTA-biomarkers in DR are becoming an important tool for screening, diagnosis, monitoring of DR, and for predicting and preventing patients' clinical response to treatment.Stargardt disease is a hereditary retinal dystrophy associated with mutations in the ABCA4 gene. Curr
Aimer
Commentaire
Partagez
